Liver transplantation for alcoholic hepatitis: A systematic review with meta-analysis. by Marot, A. et al.
RESEARCH ARTICLE
Liver transplantation for alcoholic hepatitis: A
systematic review with meta-analysis
Astrid Marot1, Margaux Dubois1, Eric Tre´po2,3, Christophe Moreno2,3, Pierre Deltenre1,2*
1 Division of Gastroenterology and Hepatology, Centre Hospitalier Universitaire Vaudois, University of
Lausanne, Lausanne, Switzerland, 2 Department of Gastroenterology, Hepatopancreatology, and Digestive
Oncology, CUB Hoˆpital Erasme, Universite´ Libre de Bruxelles, Brussels, Belgium, 3 Laboratory of
Experimental Gastroenterology, Universite´ Libre de Bruxelles, Brussels, Belgium
* pierre.deltenre01@gmail.com
Abstract
Background
The rate of alcohol relapse among patients who underwent liver transplantation for alcoholic
hepatitis (AH) is not precisely known.
Aim
Synthesize the available evidence on liver transplantation for AH to assess alcohol relapse
and 6-month survival.
Methods
Meta-analysis of trials evaluating liver transplantation for AH, either clinically severe or diag-
nosed on the explant.
Results
Eleven studies were included. The pooled estimate rate for alcohol relapse was 0.22 (95%
CI = 0.12–0.36) in overall analysis with high heterogeneity between studies (I2 = 76%), 0.20
(95% CI = 0.07–0.43) in the subgroup analysis including patients with clinically severe AH
(I2 = 84%), 0.14 (95% CI = 0.08–0.23) among patients with clinically severe AH in sensitivity
analysis excluding the discrepant studies that did not use stringent selection criteria for liver
transplantation (I2 = 0%), and 0.15 (95% CI = 0.07–0.27) for recurrent harmful alcohol con-
sumption among patients with clinically severe AH (I2 = 3%). The risk of alcohol relapse was
not different between AH transplanted patients and patients with alcoholic cirrhosis who
underwent elective liver transplantation in sensitivity analysis excluding the discrepant stud-
ies (OR = 1.68, 95%CI = 0.79–3.58, p = 0.2, I2 = 16%). The pooled estimate rate for 6-
month survival was 0.85 (95% CI = 0.77–0.91, I2 = 49%), and 0.80 among patients trans-
planted for clinically severe AH (95% CI = 0.69–0.88, I2 = 30%). AH transplanted patients
had similar 6-month survival to patients with alcoholic cirrhosis who underwent elective liver
transplantation (OR = 2.00, 95% CI = 0.95–4.23, p = 0.07, I2 = 0%).
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Conclusion
Using stringent selection criteria, 14% of patients with clinically severe AH have alcohol
relapse after liver transplantation. The percentage of alcohol relapse of AH transplanted
patients is similar than that of patients who underwent elective liver transplantation.
Introduction
The treatment of severe forms of alcoholic hepatitis (AH) remains a challenge, especially for
non-responders to corticosteroids who only have a 25% survival probability at 6 months [1].
In the absence of another therapeutic option, liver transplantation has been proposed in this
setting. In a recent study, the 6-month survival of patients with a first episode of severe AH not
responding to medical therapy who underwent early liver transplantation was significantly
better than that for non-responders who were not transplanted [2]. This study challenged the
rule that a 6-month period of abstinence should be required before considering liver trans-
plantation for patients with alcoholic liver disease.
The reasons why a 6-month abstinence period is usually applied before considering a
patient with alcoholic liver disease for liver transplantation are manifold. They include
hope that liver function will improve after alcohol withdrawal, fear of recurrent alcohol con-
sumption after liver transplantation, organ shortages, and fear that considering liver transplan-
tation in patients with a self-inflicted disease could raise a problem of equity in liver graft
allocation and in both public opinion and healthcare providers who participate in candidate
selection [3, 4]. However, a recent survey indicated that early liver transplantation for carefully
selected patients with acute AH was not as controversial with the public as previously thought
[5]. In addition, only a few patients with severe AH returned to alcohol consumption after
liver transplantation in recent studies that applied strict selection criteria for choosing candi-
dates [2, 6, 7]. Finally, previous studies among patients with alcoholic cirrhosis have indicated
that the 6-month rule of abstinence poorly identifies patients with recurrent alcohol consump-
tion after liver transplantation [8, 9]. In the setting of liver transplantation for patients with
AH, in addition to the studies performed in patients with severe AH, a couple of studies have
also identified AH on explants from patients with alcoholic liver disease, suggesting that these
patients probably did not fulfill the 6-month abstinence rule before liver transplantation [10,
11]. These studies provide additional data on alcohol relapse following liver transplantation
for AH.
Despite the large amount of data on liver transplantation for AH that already exists, the rate
of recurrent alcohol consumption after liver transplantation among patients with AH is still
not precisely known. Meta-analysis is a quantitative technique that enables pooling data from
trials in order to decrease random error. It also allows for assessment of the magnitude of
impact of a particular factor. In this study, we performed a meta-analysis of trials evaluating
liver transplantation among patients with AH. Our main objective was to assess the rate of
alcohol relapse among AH transplanted patients and to compare it to alcohol relapse rates
among patients with alcoholic cirrhosis who underwent elective liver transplantation. Our sec-
ondary objectives were to assess the rates of harmful alcohol relapse and 6-month survival
among AH transplanted patients, and to compare 6-month survival rates among AH trans-
planted patients to those of non-responders who were not transplanted or to patients with
alcoholic cirrhosis who underwent elective liver transplantation.
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DF, Maddrey’s discriminant function; NA, not
available; OR, odds ratio.
Materials and methods
Literature search
Medline (PubMed), Embase, Cochrane library, and manual searches were combined and last
performed on June 10th, 2017. Key search terms were “alcoholic hepatitis”, “abstinence”, “alco-
hol relapse”, and “liver transplantation”. Terms were combined within each database. General
reviews and references from published trials were also used. The exact search term combina-
tions can be found in the S1 Appendix. Duplicate were excluded. No language restriction was
applied. Two observers (A.M. and M.D.) also screened all abstracts presented between 2014
and 2017 at the Liver Meeting of the American Association for the Study of Liver Diseases
(AASLD) and the International Liver Congress of the European Association for the Study of
the Liver (EASL).
Criteria for inclusion and exclusion of studies
All observational studies were included. In order to reduce risk of bias, strict inclusion and
exclusion criteria were defined prior to the literature search. To be considered, a study had to:
a) include patients with AH, either patients with acute jaundice and severe AH or patients
with alcoholic cirrhosis who underwent a liver transplantation and in whom the diagnosis of
AH was made on the explant; b) provide data relative to alcohol consumption or survival after
liver transplantation. When several publications were found covering the same study popula-
tion, only the most recent was taken into account.
Endpoints
Endpoints were defined prior to the beginning of the meta-analysis. The main endpoint was
alcohol relapse defined as any alcohol consumption after liver transplantation. The secondary
endpoints were harmful drinking defined as binge, frequent, regular or daily drinking, and
6-month survival.
Data extraction
Data extraction was performed independently by two investigators (A.M. and M.D.) using stan-
dardized data collection forms. Discrepancies in data interpretation were resolved by discus-
sion, re-review of the studies and consultation with one other author (P.D.) when necessary.
Quality score
The methodological quality of studies was assessed using the Newcastle Ottawa Scale for
cohort studies [12].
Statistical analysis
We used a random effects model to obtain a summary estimate of primary outcomes among
patients with AH. The random-effects model was chosen because it takes into account the possi-
bility of heterogeneity between studies [13]. Data on all patients were extracted to allow inten-
tion-to-treat analyses. We calculated event rates among patients with AH, a measure of how
often a particular statistical event occurs within a group in an experiment, with 95% confidence
intervals (CI), as already done elsewhere [14–16]. Differences between groups are expressed as
odds ratios (ORs) with 95% CIs. A p-value<0.05 was considered statistically significant.
As a first step, an overall meta-analysis was performed. This analysis included transplanted
patients with clinically severe AH and transplanted patients in whom the diagnosis of AH was
Liver transplantation for alcoholic hepatitis
PLOS ONE | https://doi.org/10.1371/journal.pone.0190823 January 11, 2018 3 / 14
made on the explant. In a second step, subgroup analyses in patients with and without clini-
cally severe AH were performed. The overall analysis also included studies comparing AH
transplanted patients to non-responders to medical therapy who were not transplanted, or to
patients with alcoholic cirrhosis but without AH who underwent elective liver transplantation.
In a third step, subgroup analyses comparing AH transplanted patients to non-responders to
medical therapy who were not transplanted or to patients with alcoholic cirrhosis but without
AH who underwent elective liver transplantation were performed.
Heterogeneity was assessed by Cochran’s Q test [17] and the I2 statistic. More specifically,
the I2 statistic was used to estimate inconsistency in the meta-analysis, representing the per-
centage of the between-study variability due to heterogeneity rather than chance [18]. A signif-
icant Cochran’s Q-statistic (below 0.10) was chosen as a threshold for significant heterogeneity
across studies. The following cut-offs were used to quantify heterogeneity with the I2 statistic:
0–25%, low; 25–50%, moderate; >50%, high heterogeneity [18]. In cases of moderate or high
heterogeneity, the methodological section of each study was re-reviewed to determine whether
any discrepancy could be identified, and sensitivity analyses excluding the discrepant study
were performed. To assess the extent of publication bias, the Egger test, the Begg and Mazum-
dar test and the Trim and Fill adjustment were used [17, 19]. A p-value <0.05 was considered
statistically significant. All statistical analyses were performed using Comprehensive Meta-
analysis (Biostat, Englewood, NJ).
Results
Study population
Fig 1 summarizes the flow chart of the selection of studies for inclusion in the meta-analysis.
We screened 1130 references; 485 were selected for full-text retrieval. Of these, 11 were
included in the analysis [2, 7, 10, 11, 20–26]. One study [27] which was a national registry that
included patients from 2 other studies [7, 21] was excluded to avoid duplication of data.
Table 1 summarizes the main characteristics of the studies included in the meta-analysis. A
total of 325 patients with AH were included. There were 240 patients with clinically severe AH
and 85 patients in whom the diagnosis of AH was made on the explant.
Study quality
S1 Table details the quality of the studies included.
Methodological assessment of studies
With the exception of the Mathurin’s study [2], all studies were retrospective (Table 1). The
methodological analysis of each study identified discrepancies in 2 of them [22, 25]. In these
studies, either active consumers or patients abstinent only for a very short period of time were
intentionally transplanted without using stringent criteria for selecting candidates for liver
transplantation as has been done in the most recent studies (Table 1). These criteria included
patients’ motivation to stay abstinent of alcohol following liver transplantation, a good psycho-
social support and/or a favorable patient psychological profile. In cases of moderate or high
heterogeneity in subgroup analyses, sensitivity analyses excluding the Shakil [22] and the Van
Thiel [25] studies were performed.
Outcomes
Risk of alcohol relapse after liver transplantation. The pooled estimate rate for alcohol
relapse was 0.22 (95% CI = 0.12–0.36, Fig 2 and Table 2). There was high heterogeneity
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between studies (p<0.001, I2 = 76%). Publication bias was detected by the Egger test (p = 0.02)
but not by the Begg and Mazumdar test (p = 0.7). Funnel plot are shown in S1 Fig, including
results using the Trim and Fill adjustment.
Results of subgroup analyses including only patients with clinically severe AH are reported
as Supporting Information (S2 Table). The pooled estimate rate for alcohol relapse was 0.20
(95% CI = 0.07–0.43). There was high heterogeneity between studies (p<0.001, I2 = 84%). In
sensitivity analysis excluding studies that did not use stringent criteria for selecting candidates
for liver transplantation, the pooled estimate rate for alcohol relapse was 0.14 (95% CI = 0.08–
0.23), with no heterogeneity between studies (p = 0.6, I2 = 0%). The rate for harmful alcohol
relapse was 0.15 (95% CI = 0.07–0.27), with negligible heterogeneity between studies (p = 0.4,
I2 = 3%).
Results of subgroup analyses including only patients in whom the diagnosis of AH was
made on the explant are reported as Supporting Information (S2 Table). The pooled estimate
rate for alcohol relapse was 0.23 (95% CI = 0.11–0.43). There was high heterogeneity between
Fig 1. Flow chart of the selection of studies for inclusion in the meta-analysis.
https://doi.org/10.1371/journal.pone.0190823.g001
Liver transplantation for alcoholic hepatitis
PLOS ONE | https://doi.org/10.1371/journal.pone.0190823 January 11, 2018 5 / 14
T
a
b
le
1
.
C
h
a
ra
ct
er
is
ti
cs
o
f
th
e
1
1
in
cl
u
d
ed
st
u
d
ie
s.
R
ef
er
en
ce
s
S
tu
d
y
d
es
ig
n
N
o
f
p
a
ti
en
ts
w
it
h
A
H
T
y
p
e
o
f
A
H
A
g
e
(y
ea
rs
)
M
a
le
(%
)
H
is
to
lo
g
ic
a
ll
y
p
ro
v
en
A
H
D
u
ra
ti
o
n
o
f
a
b
st
in
en
ce
b
ef
o
re
li
v
er
tr
a
n
sp
la
n
ta
ti
o
n
C
ri
te
ri
a
fo
r
se
le
ct
in
g
p
a
ti
en
ts
fo
r
li
v
er
tr
a
n
sp
la
n
ta
ti
o
n
M
E
L
D
sc
o
re
M
a
d
d
re
y
D
F
F
ir
st
ep
is
o
d
e
o
f
A
H
G
o
o
d
p
sy
ch
o
so
ci
a
l
su
p
p
o
rt
a
n
d
/o
r
fa
v
o
ra
b
le
p
sy
ch
o
lo
g
ic
a
l
p
ro
fi
le
N
o
n
-r
es
p
o
n
se
to
m
ed
ic
a
l
th
er
a
p
y
S
o
b
ri
et
y
co
n
tr
a
ct
#
N
o
f
cr
it
er
ia
H
an
o
u
n
eh
2
0
1
4
(2
0
)
R
et
ro
sp
ec
ti
v
e
2
9
S
ev
er
e
N
A
N
A
N
A
N
A
N
A
Y
es
Y
es
Y
es
3
/4
3
5
1
1
0
Im
2
0
1
6
(2
1
)
R
et
ro
sp
ec
ti
v
e
1
6
S
ev
er
e
4
1

˚
5
6
% ˚
Y
es
3
3
d
ay
s
b
ef
o
re
li
st
in
g
fo
r
li
v
er
tr
an
sp
la
n
ta
ti
o
n


˚
Y
es
in
8
9
%
o
f
p
at
ie
n
ts
˚
Y
es
Y
es
Y
es
4
/4
3
9

9
2

˚
Im
m
o
rd
in
o
2
0
0
9
(1
0
)
R
et
ro
sp
ec
ti
v
e
8
D
ia
g
n
o
se
d
o
n
th
e
li
v
er
ex
p
la
n
t
5
3
˚˚
8
6
%
˚˚
Y
es
N
A
–
1
4
˚˚
N
A
L
ee
2
0
1
7
(7
)
R
et
ro
sp
ec
ti
v
e
1
7
S
ev
er
e
5
0


7
6
%
Y
es
4
0
d
ay
s
Y
es
Y
es
Y
es
Y
es
4
/4
3
7

6
7

˚˚
˚
M
at
h
u
ri
n
2
0
1
1
(2
)
P
ro
sp
ec
ti
v
e
2
6
S
ev
er
e
4
7

5
8
%
Y
es
fo
r
m
o
st
o
f
th
e
p
at
ie
n
ts
<
3
m
o
n
th
s
Y
es
Y
es
Y
es
Y
es
4
/4
3
4

7
6

˚˚
˚˚
S
h
ak
il
1
9
9
7
(2
2
)
R
et
ro
sp
ec
ti
v
e
9
#
#
D
ia
g
n
o
se
d
o
n
th
e
li
v
er
ex
p
la
n
ts
4
1


8
9
%
Y
es

1
m
o
n
th
fo
r
6
p
at
ie
n
ts
–
N
A
4
7


S
id
d
ac
h
ar
i
2
0
1
4
(2
3
)
R
et
ro
sp
ec
ti
v
e
3
3
S
ev
er
e
4
6


N
A
N
A
N
A
N
A
Y
es
Y
es
N
A
2
/4
3
0


9
1


S
in
g
al
2
0
1
2
(2
4
)
R
et
ro
sp
ec
ti
v
e
5
5
S
ev
er
e
5
2


7
6
%
N
o
fo
r
m
o
st
o
f
th
e
p
at
ie
n
ts
<
3
m
o
n
th
s
W
el
l-
se
le
ct
ed
g
ro
u
p
o
f
A
H
p
at
ie
n
ts
2
6


N
A
T
o
m
e´
2
0
0
2
(1
1
)
R
et
ro
sp
ec
ti
v
e
3
6
D
ia
g
n
o
se
d
o
n
th
e
li
v
er
ex
p
la
n
t
5
1

9
2
%
Y
es
1
5
m
o
n
th
s

–
N
A
7
2
%
<
3
2
2
8
%

3
2
V
an
T
h
ie
l
1
9
9
5
(2
5
)
R
et
ro
sp
ec
ti
v
e
6
4
S
ev
er
e
4
7


7
3
%
Y
es
A
ll
p
at
ie
n
ts
w
er
e
ac
ti
v
e
co
n
su
m
er
s
N
A
N
o
N
A
N
o
0
/4
N
A
N
A
W
el
ls
2
0
0
7
(2
6
)
R
et
ro
sp
ec
ti
v
e
3
2
D
ia
g
n
o
se
d
o
n
th
e
ex
p
la
n
t
5
0


6
9
%
Y
es
9
.7
m
o
n
th
s


–
2
1


3
8


A
b
b
re
v
ia
ti
o
n
s:
N
A
,
n
o
t
av
ai
la
b
le
;
A
H
,a
lc
o
h
o
li
c
h
ep
at
it
is

E
x
p
re
ss
ed
as
m
ed
ia
n


E
x
p
re
ss
ed
as
m
ea
n
˚
D
at
a
ex
tr
ac
te
d
fr
o
m
re
f.
[6
]
˚˚
D
at
a
ex
tr
ac
te
d
fr
o
m
th
e
w
h
o
le
st
u
d
y
p
o
p
u
la
ti
o
n
tr
an
sp
la
n
te
d
˚˚
˚
M
is
si
n
g
v
al
u
es
in
2
p
at
ie
n
ts
˚˚
˚˚
D
at
a
at
th
e
fi
rs
t
d
ay
o
f
m
ed
ic
al
th
er
ap
y
#
S
o
b
ri
et
y
co
n
tr
ac
t
m
ea
n
s
o
ra
l
o
r
w
ri
tt
en
co
n
tr
ac
t
ag
re
ei
n
g
to
st
ay
ab
st
in
en
t
o
f
al
co
h
o
l
af
te
r
li
v
er
tr
an
sp
la
n
ta
ti
o
n
#
#
1
7
p
at
ie
n
ts
h
ad
ty
p
ic
al
h
is
to
lo
g
ic
al
fe
at
u
re
s
A
H
o
n
th
e
li
v
er
ex
p
la
n
ts
b
u
t
o
n
ly
9
p
at
ie
n
ts
fu
lf
il
le
d
th
e
cr
it
er
io
n
o
f
se
v
er
e
A
H
w
it
h
D
F
>
3
2
an
d
w
er
e
an
al
y
ze
d
in
th
is
st
u
d
y
h
tt
p
s:
//
d
o
i.o
rg
/1
0
.1
3
7
1
/jo
u
rn
al
.p
o
n
e.
0
1
9
0
8
2
3
.t
0
0
1
Liver transplantation for alcoholic hepatitis
PLOS ONE | https://doi.org/10.1371/journal.pone.0190823 January 11, 2018 6 / 14
studies (p = 0.09, I2 = 54%). In sensitivity analysis excluding studies that did not use stringent
criteria for selecting candidates for liver transplantation, the pooled estimate rate for alcohol
relapse was 0.19 (95% CI = 0.08–0.38), with high heterogeneity between studies (p = 0.1, I2 =
54%). The rate for harmful alcohol relapse was not assessed in this subgroup analysis due to
the limited number of studies with available data.
AH transplanted patients had a non-significantly different risk of alcohol relapse compared
to patients with alcoholic cirrhosis who underwent elective liver transplantation (OR = 2.28,
95% CI = 0.98–5.29, p = 0.055), with high heterogeneity between studies (p = 0.05, I2 = 59%).
In the sensitivity analysis excluding studies that did not use stringent criteria for selecting can-
didates for liver transplantation, AH transplanted patients had a similar risk of alcohol relapse
compared to patients with alcoholic cirrhosis who underwent elective liver transplantation
(OR = 1.68, 95% CI = 0.79–3.58, p = 0.2, Fig 3), with low heterogeneity between studies (p =
0.3, I2 = 16%). Subgroup analysis including only patients with severe AH was not done due to
the limited number of studies with available data. In the subgroup analysis including only
patients in whom the diagnosis of AH was made on the explants, the risk of alcohol relapse
was higher among AH transplanted patients than in those who underwent elective liver trans-
plantation (OR = 2.3, 95% CI = 1.08–4.89, p = 0.03), with no heterogeneity among studies
(p = 0.4, I2 = 0%).
6-month survival. The pooled estimate rate for 6-month survival was 0.85 (95%
CI = 0.77–0.91, Fig 4 and Table 2). There was high heterogeneity between studies (p = 0.05,
I2 = 49%). Publication bias was detected by the Egger test (p = 0.01) and by the Begg and
Mazumdar test (p = 0.06). Funnel plot are shown in S2 Fig, including results using the Trim
and Fill adjustment.
Fig 2. Pooled estimate rate of alcohol relapse after liver transplantation among AH transplanted patients. CI, confidence interval.
https://doi.org/10.1371/journal.pone.0190823.g002
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Results of subgroup analyses including only patients with clinically severe AH are reported
as Supporting Information (S2 Table). The pooled estimate rate for 6-month survival was 0.80
(95% CI = 0.69–0.88), with moderate heterogeneity between studies (p = 0.2, I2 = 30%).
Table 2. Alcohol relapse and 6-month survival after liver transplantation among the 11 included studies.
References Groups of patients N Alcohol
relapse
(n)
Harmful alcohol
relapse
(n)
6-month
survival
(%)
Hanouneh
2014
(20)
AH transplanted patients 29 NA£ NA 87%
Im 2016
(21)
AH transplanted patients 16 2 2££ 88%
Non-responders to corticoids who were
not transplanted
152 – – 19%
Immordino
2009
(10)
AH transplanted patients 8 1 NA NA
Patients with alcoholic cirrhosis who
were transplanted
102 12 NA NA
Lee 2017
(7)
AH transplanted patients 17 4 4£££ 100%
Patients with alcoholic cirrhosis who
were transplanted
26 7˚ 3£££ 88%
Mathurin 2011
(2)
AH transplanted patients 26 3 2££££ 77%
Non-responders to corticoids who were
not transplanted
26 – – 23%
Shakil 1997
(22)
AH transplanted patients 9 3˚˚ NA 89%
Siddachari
2014
(23)
AH transplanted patients 33 3 NA 70%
Patients with alcoholic cirrhosis who
were transplanted
127 11 NA NA
Singal 2012
(24)
AH transplanted patients 55 NA NA 95%˚˚˚
Patients with alcoholic cirrhosis who
were transplanted
165 NA NA 90%˚˚˚
Tome´ 2002
(11)
AH transplanted patients 36 4 NA˚˚˚˚ 79%˚˚˚
Patients with alcoholic cirrhosis who
were transplanted
32 3 NA˚˚˚˚ 72%˚˚˚
Van Thiel
1995
(25)
AH transplanted patients 64 33 NA NA
Patients with alcoholic cirrhosis who
were transplanted
145 22 NA NA
Wells 2007
(26)
AH transplanted patients 32 10 8£££££ 96%˚˚˚
Patients with alcoholic cirrhosis who
were transplanted
116 14 12£££££ 86%˚˚˚
Abbreviations: NA, not available; AH, alcoholic hepatitis
˚ Data among 24 patients (2 patients who died during the immediate postoperative period were excluded from this
analysis)
˚˚ Data on alcohol relapse available in only 6 patients
˚˚˚ Data extrapolated from survival curves
˚˚˚˚ In ref. [11], data on harmful alcohol relapse are pooled for AH patients and patients with alcoholic cirrhosis
£ Discordant results in the abstract did not allow for extraction of accurate data
££ Alcohol relapse was defined as alcohol consumption of 4 or more drinks in a day or at least one drink for 4 or
more days in succession after liver transplantation (harmful drinking)
£££ Harmful alcohol relapse was defined as alcohol relapse with binge drinking or frequent patterns defined as any
alcohol consumption on 4 days in a week
££££ Harmful alcohol relapse was defined as daily alcohol consumption
£££££ Harmful alcohol relapse was defined as 6 alcoholic drinks in one day
https://doi.org/10.1371/journal.pone.0190823.t002
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Results of subgroup analyses including only patients in whom the diagnosis of AH was
made on the explant are reported as Supporting Information (S2 Table). The pooled estimate
rate for 6-month survival was 0.90 (95% CI = 0.76–0.97), with high heterogeneity between
studies (p = 0.06, I2 = 60%). In sensitivity analysis excluding studies that did not use stringent
criteria for selecting candidates for liver transplantation, the pooled estimate rate for 6-month
survival was 0.91 (95% CI = 0.72–0.98), with high heterogeneity between studies (p = 0.02, I2 =
73%).
Fig 3. Risk of alcohol relapse after liver transplantation between AH transplanted patients and patients with alcoholic cirrhosis who underwent elective liver
transplantation in sensitivity analysis excluding studies that did not use stringent criteria for selecting candidates for liver transplantation. CI, confidence interval;
OR, odds ratio.
https://doi.org/10.1371/journal.pone.0190823.g003
Fig 4. Pooled estimate rate for survival at 6 months among AH transplanted patients. CI, confidence interval.
https://doi.org/10.1371/journal.pone.0190823.g004
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AH transplanted patients had better 6-month survival than did non-responders to corti-
coids who were not transplanted (OR = 16.69, 95% CI = 6.21–44.81, p<0.001), with no hetero-
geneity between studies (p = 0.3, I2 = 0%).
AH transplanted patients had similar 6-month survival compared to patients with alcoholic
cirrhosis who underwent elective liver transplantation (OR = 2.00, 95% CI = 0.95–4.23,
p = 0.07), with no heterogeneity between studies (p = 0.7, I2 = 0%). Subgroup analyses includ-
ing only patients with severe AH were not done due to the limited number of studies with
available data. In the subgroup analysis including only patients in whom the diagnosis of AH
was made on the explants, AH patients had similar 6-month survival compared to patients
who underwent elective liver transplantation (OR = 1.88, 95% CI = 0.87–4.07, p = 0.1), with
no heterogeneity among studies (p = 0.6, I2 = 0%).
Discussion
The increasing recognition of liver transplantation as a rescue therapy for patients with severe
AH not responding to medical therapy has challenged the 6-month rule of abstinence. This
rule, which poorly identifies patients with alcoholic liver disease who will have recurrent alco-
hol use after liver transplantation [8, 9], is not applicable to patients with severe AH who have
no other therapeutic option and who have a high risk of death within 6 months after the onset
of the disease. Since the landmark study of Mathurin et al. in 2011 [2], several teams have
reported their first experience with early liver transplantation among patients with severe AH.
In addition, a couple of studies have reported on the outcomes of patients transplanted for
alcoholic cirrhosis in which AH was discovered on the explants. Despite using a different selec-
tion process than the one used for patients with clinically severe AH, these studies provide
additional data on the behavior of AH patients following liver transplantation. As a result,
there are quite a lot of data currently available on the risk of alcohol relapse among AH trans-
planted patients. Thus, a meta-analysis is required to synthesize available data.
This meta-analysis found that only one-fifth of AH patients had alcohol relapse after liver
transplantation. The percentage of AH transplanted patients with alcohol relapse was not sig-
nificantly different than that of patients with alcoholic cirrhosis who underwent elective liver
transplantation with the exception of patients in whom the diagnosis of AH was made on the
explant. In these cases, proper selection of candidates for liver transplantation was less likely
than in patients not responding to corticosteroids and who, in the end, were transplanted. Of
note, after the exclusion of a discrepant study that did not use stringent criteria for selecting
candidates for liver transplantation, only 14% of patients with clinically severe AH had alcohol
relapse after liver transplantation. However, in cases of recurrence, most patients had harmful
drinking patterns as has already been shown for patients transplanted for alcoholic cirrhosis
after a 6-month sobriety period [28]. Overall, these results indicate that the selection of AH
patients for liver transplantation should be based on stringent criteria, as has been done in the
most recent studies [2, 6]. Currently, the use of such strict selection process seems to be a key
factor that allows for selection of patients with a low risk of alcohol relapse after liver
transplantation.
This meta-analysis confirmed that liver transplantation considerably improved the progno-
sis of patients with severe AH who were not responding to medical therapy. The pooled esti-
mate rate for survival was 85% at 6 months among all AH transplanted patients and 80%
among patients with clinically severe AH. This was much better than the rate for non-trans-
planted non-responder patients. In addition, AH transplanted patients had similar 6-month
survival compared to patients with alcoholic cirrhosis who underwent elective liver transplan-
tation. However, data on long-term prognosis were not available. This could be a matter of
Liver transplantation for alcoholic hepatitis
PLOS ONE | https://doi.org/10.1371/journal.pone.0190823 January 11, 2018 10 / 14
concern among AH patients with recurrent alcohol consumption as alcohol relapse is likely to
impact long-term prognosis. Nevertheless, as liver transplantation can only be proposed to a
limited number of patients, alternative pharmacological therapies should be developed for
patients who are not responding to medical therapy to reduce the number of potential candi-
dates for liver transplantation.
We acknowledge that this meta-analysis has several limitations. One set of limitations is
related to the fact that AH was not confirmed with a liver biopsy in all patients with clinically
severe AH, to the retrospective design of most studies, and to the limited number of patients.
However, it was expected that most studies dealing with non-responder transplanted AH
patients were retrospective and included few patients. In addition, individual participant data
and data related to the effect of alcohol relapse according to the pattern of drinking would
have been of interest but, unfortunately, they were not available. Another limitation is the exis-
tence of publication bias detected regarding the risk of alcohol relapse and 6-month survival,
despite our efforts to limit this risk as much as possible using a number of methods. However,
the impact of this bias was probably modest. Another issue lies with the criteria used for select-
ing patients for liver transplantation that were not uniform between studies. A classical limita-
tion of meta-analyses is also related to the presence of heterogeneity that may prevent making
robust conclusions and recommendations. This suggests that a substantial proportion of the
difference in the effect between studies cannot only be explained by random sampling but by
true differences between studies. In this meta-analysis, high heterogeneity was found for sev-
eral analyses on the risk of alcohol relapse and survival. However, heterogeneity was always
reduced and even disappeared in subgroup analyses or when discrepant studies that did not
use stringent criteria for selecting candidates for liver transplantation were excluded. There-
fore, the results of these analyses seem robust for assessment of the rate of alcohol relapse
among AH transplanted patients even if they are based on a limited number of studies. Never-
theless, prospective studies using stringent selection criteria are still needed. In line with this,
the first results of an ongoing prospective observation trial focusing on alcohol relapse after
liver transplantation (NCT01756794) expected at the beginning of 2018 will be of interest.
This study may contribute to the identification of factors predicting alcohol relapse after liver
transplantation in daily practice.
In summary, 14% of carefully selected patients with clinically severe AH not responding to
medical therapy have alcohol relapse after liver transplantation. When rigorous criteria for
selecting candidates for liver transplantation are applied, the percentage of alcohol relapse of
AH transplanted patients is not different than that of patients with alcoholic cirrhosis who
underwent elective liver transplantation. Stringent selection criteria should be defined and
applied when considering liver transplantation in patients with AH.
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S1 Fig. Funnel plot of studies evaluating alcohol relapse. As the shape of the funnel plot for
the studies was not symmetrical, the Duval and Tweedie’s Trim and Fill adjustment was used
to estimate the extent of the impact of the bias and what the effect size would have been in the
absence of bias. It re-computes the effect size at each iteration until the funnel plot is symmet-
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studies are shown in red open circles and the imputed point estimate in log units is shown as a
red diamond. Overall, the impact of bias was probably modest.
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